<DOC>
	<DOCNO>NCT02907398</DOCNO>
	<brief_summary>Inspire intend conduct registry : 1 ) collect Inspire therapy clinical evidence clinical practice setting ; 2 ) collect additional information effectiveness , use safety commercial setting ; 3 ) engage physician customer report collective outcome within group properly train program utilize Inspire therapy regular basis .</brief_summary>
	<brief_title>Adherence Outcome Upper Airway Stimulation ( UAS ) OSA International Registry</brief_title>
	<detailed_description>This registry multi-center , prospective , observational registry , conduct United States Europe . Some data may collect retrospectively patient currently implant ( implanted prior enrollment ) 12-month follow-up time frame . The CE-marked FDA-approved Inspire system use within intend use , allow use future approve system component model . This protocol include additional stressful invasive test , part standard care .</detailed_description>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Any patient implant receive Inspire implant , meet follow criterion , eligible participate registry : 1 . Must legal adult 2 . Capable give informed consent , require per institution 3 . Willing return routine clinic visit require Inspire therapy management Any patient meet follow criterion eligible participate registry 1 . Has life expectancy le 1 year 2 . Any reason clinician deem patient unfit participation study</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Neurostimulation</keyword>
	<keyword>Hypoglossal nerve</keyword>
	<keyword>Tongue</keyword>
	<keyword>Upper airway stimulation</keyword>
	<keyword>Surgery</keyword>
</DOC>